Close

BioMarin Pharma (BMRN) Adds Former Allergan CEO as Director

January 4, 2016 8:32 AM EST Send to a Friend
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced that David Pyott has been elected to the company’s board of directors. Mr ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login